000168372 001__ 168372
000168372 005__ 20240229133606.0
000168372 0247_ $$2doi$$a10.1038/s41379-021-00804-y
000168372 0247_ $$2pmid$$apmid:33846547
000168372 0247_ $$2ISSN$$a0893-3952
000168372 0247_ $$2ISSN$$a1530-0285
000168372 0247_ $$2altmetric$$aaltmetric:103752101
000168372 037__ $$aDKFZ-2021-00861
000168372 041__ $$aEnglish
000168372 082__ $$a610
000168372 1001_ $$0P:(DE-He78)0da1ad006d075546f49fd10e062da5d2$$aKommoss, Felix Karl-Friedrich$$b0$$eFirst author$$udkfz
000168372 245__ $$aClinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup.
000168372 260__ $$aLondon$$bNature Publishing Group$$c2021
000168372 3367_ $$2DRIVER$$aarticle
000168372 3367_ $$2DataCite$$aOutput Types/Journal article
000168372 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1628163536_25573
000168372 3367_ $$2BibTeX$$aARTICLE
000168372 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000168372 3367_ $$00$$2EndNote$$aJournal Article
000168372 500__ $$a#EA:B380#LA:B300# / 2021 Aug;34(8):1558-1569
000168372 520__ $$aEmbryonal rhabdomyosarcoma (ERMS) of the uterus has recently been shown to frequently harbor DICER1 mutations. Interestingly, only rare cases of extrauterine DICER1-associated ERMS, mostly located in the genitourinary tract, have been reported to date. Our goal was to study clinicopathologic and molecular profiles of DICER1-mutant (DICER1-mut) and DICER1-wild type (DICER1-wt) ERMS in a cohort of genitourinary tumors. We collected a cohort of 17 ERMS including nine uterine (four uterine corpus and five cervix), one vaginal, and seven urinary tract tumors. DNA sequencing revealed mutations of DICER1 in 9/9 uterine ERMS. All other ERMS of our cohort were DICER1-wt. The median age at diagnosis of patients with DICER1-mut and DICER1-wt ERMS was 36 years and 5 years, respectively. Limited follow-up data (available for 15/17 patients) suggested that DICER1-mut ERMS might show a less aggressive clinical course than DICER1-wt ERMS. Histological features only observed in DICER1-mut ERMS were cartilaginous nodules (6/9 DICER1-mut ERMS), in one case accompanied by foci of ossification. Recurrent mutations identified in both DICER1-mut and DICER1-wt ERMS affected KRAS, NRAS, and TP53. Copy number analysis revealed similar structural variations with frequent gains on chromosomes 2, 3, and 8, independent of DICER1 mutation status. Unsupervised hierarchical clustering of array-based whole-genome DNA methylation data of our study cohort together with an extended methylation data set including different RMS subtypes from genitourinary and extra-genitourinary locations (n = 102), revealed a distinct cluster for DICER1-mut ERMS. Such tumors clearly segregated from the clusters of DICER1-wt ERMS, alveolar RMS, and MYOD1-mutant spindle cell and sclerosing RMS. Only one tumor, previously diagnosed as ERMS arising in the maxilla of a 6-year-old boy clustered with DICER1-mut ERMS of the uterus. Subsequent sequencing analysis identified two DICER1 mutations in the latter case. Our results suggest that DICER1-mut ERMS might qualify as a distinct subtype in future classifications of RMS.
000168372 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000168372 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000168372 7001_ $$0P:(DE-He78)d20d08adc992abdb6ccffa1686f1ba17$$aStichel, Damian$$b1$$udkfz
000168372 7001_ $$aMora, Jaume$$b2
000168372 7001_ $$aEsteller, Manel$$b3
000168372 7001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David$$b4$$udkfz
000168372 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan M$$b5$$udkfz
000168372 7001_ $$aBrack, Eva$$b6
000168372 7001_ $$aWachtel, Marco$$b7
000168372 7001_ $$00000-0002-9633-4042$$aBode, Peter Karl$$b8
000168372 7001_ $$00000-0003-2836-6699$$aSinn, Hans-Peter$$b9
000168372 7001_ $$aSchmidt, Dietmar$$b10
000168372 7001_ $$aMentzel, Thomas$$b11
000168372 7001_ $$aKommoss, Friedrich$$b12
000168372 7001_ $$0P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aSahm, Felix$$b13$$udkfz
000168372 7001_ $$0P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$avon Deimling, Andreas$$b14$$eLast author$$udkfz
000168372 7001_ $$00000-0001-8763-8864$$aKoelsche, Christian$$b15
000168372 773__ $$0PERI:(DE-600)2041318-X$$a10.1038/s41379-021-00804-y$$n8$$p1558-1569$$tModern pathology$$v34$$x1530-0285$$y2021
000168372 909CO $$ooai:inrepo02.dkfz.de:168372$$pVDB
000168372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0da1ad006d075546f49fd10e062da5d2$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000168372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d20d08adc992abdb6ccffa1686f1ba17$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000168372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000168372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000168372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000168372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000168372 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000168372 9130_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000168372 9141_ $$y2021
000168372 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMODERN PATHOL : 2019$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-28
000168372 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bMODERN PATHOL : 2019$$d2021-01-28
000168372 9201_ $$0I:(DE-He78)B380-20160331$$kB380$$lNWG Weichteil-Sarkome$$x0
000168372 9201_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x1
000168372 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000168372 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPediatric Glioma$$x3
000168372 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x4
000168372 980__ $$ajournal
000168372 980__ $$aVDB
000168372 980__ $$aI:(DE-He78)B380-20160331
000168372 980__ $$aI:(DE-He78)B300-20160331
000168372 980__ $$aI:(DE-He78)HD01-20160331
000168372 980__ $$aI:(DE-He78)B360-20160331
000168372 980__ $$aI:(DE-He78)B062-20160331
000168372 980__ $$aUNRESTRICTED